Atlas Trials

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

Clinical trial NCT05587712 · RECRUITING

Trial details

NCT number
NCT05587712
Sponsor
Merck Sharp & Dohme LLC
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2023-01-19
Primary completion
2028-09-21
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.